Read this May 2018 commentary on the 340B program from Bruce Siegel, MD, MPH, president and CEO of America’s Essential Hospitals.

340B Commentaries by Essential Hospital Leaders

340B: A Lifeline to Life (from Harris Health System, Houston)

Congress should save this program that helps provide medicine to low-income Texans
Restricting access to 340B would fray the safety net and have serious consequences for people living on the edge of poverty who struggle to pay for their care, says R. William Whitman, senior executive vice president and chief operating officer of JPS Health Network, says in this Fort Worth Star-Telegram opinion piece. (July 23, 2018)

In a time of rising drug prices, preserve the 340B program
UAB Health System President and CEO Will Ferniany, PhD, and Ascension Healthcare executive Jason Alexander call on Congress to preserve the integrity of the 340B program in this Birmingham News commentary. (May 29, 2018)

A lifeline for Alabama patients
Writing in the Opelika-Auburn News, East Alabama Medical Center’s director of pharmacy services, Chuck Beams, says the 340B program is the difference between life and death for the most vulnerable patients in the community. (April 30, 2018)

Opinion: Successful 340B Outpatient Drug Program a Bargain for Taxpayers
In this Times of San Diego commentary, UC San Diego Health CEO Patty Maysent and Pharmacist-in-Chief Charles Daniels say the facts are clear: the 340B Drug Pricing Program provides big benefits without big government. (March 19, 2018)

Drug discount program saves lives
Bon Secours Director of Pharmacy Services Esther Alabi and Chief Nursing Officer Shelly Buck write in a Baltimore Sun commentary that losing the 340B program would compromise the Baltimore hospital’s ability to serve all patients and would put critical services at risk. (Feb. 22, 2016)